Position in LH
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,058,120
+$35,971 QoQ
Shares Held
3,779
-1.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#456
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $199,210,953 across 8 Diagnostics & Research names. LH ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
678,343 | $129,210,774 | |
| 2 | A |
Agilent Technologies, Inc.
|
431,792 | $57,354,931 | |
| 3 | NTRA |
Natera, Inc.
|
22,899 | $6,215,933 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
5,851 | $2,933,457 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,731 | $1,437,707 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
3,779 | $1,058,120 | |
| 7 | WAT |
Waters Corp /De/
|
1,498 | $561,809 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,268 | $438,222 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,058,120 | 3,779 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,022,149 | 3,831 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $956,103 | 3,811 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,123,552 | 3,914 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,024,051 | 3,901 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $865,792 | 3,720 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $914,757 | 3,989 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $840,284 | 3,760 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $763,569 | 3,752 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||